![Kristina Torfgård](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kristina Torfgård
Directeur Général chez
IRLAB THERAPEUTICS AB
Profil
Kristina Torfgård is currently Chief Executive Officer at IRLAB Therapeutics AB since 2024.
Formerly, Chief Executive Officer at Alzinova AB from 2019 to 2024.
Principal at AstraZeneca AB. Vice President-Clinical & Regulatory Affairs at Albireo Ltd. VP-Clinical, Regulatory Affairs & Global Project at Albireo AB from 2014 to 2017.
Vice President-Clinical & Regulatory Affairs at Albireo Pharma, Inc. from 2017 to 2019.
Education includes a doctorate from the University of Linköping.
Postes actifs de Kristina Torfgård
| Sociétés | Poste | Début |
|---|---|---|
| IRLAB THERAPEUTICS AB | Directeur Général | 01/08/2024 |
Anciens postes connus de Kristina Torfgård
| Sociétés | Poste | Fin |
|---|---|---|
| ALZINOVA AB | Directeur Général | 31/07/2024 |
| ALBIREO PHARMA, INC. | Directeur Technique/Scientifique/R&D | - |
Albireo AB
 Albireo AB Pharmaceuticals: MajorHealth Technology Develops bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders | Conseiller Juridique Général | 01/02/2017 |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Corporate Officer/Principal | - |
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Develops therapies that address medical needs in the gastrointestinal and liver disease area | Conseiller Juridique Général | - |
Formation de Kristina Torfgård
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
14
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
University of Linköping
 University of Linköping Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albireo Ltd.
Albireo Ltd. Pharmaceuticals: MajorHealth Technology Develops therapies that address medical needs in the gastrointestinal and liver disease area | Health Technology |
Albireo AB
Albireo AB Pharmaceuticals: MajorHealth Technology Develops bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders | Health Technology |
Alzinova AB
 Alzinova AB Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides treatment for Alzheimer’s disease | Health Technology |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
IRLAB Therapeutics AB
 IRLAB Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for neurological diseases | Health Technology |
